The focus of SPECT on DLB has been on the demonstration of alterations in the dopamine transporter (DAT), reflecting changes in the nigrostriatal pathway, and the analyses of cerebral perfusion and metabolism. Here, SLC6A3 is linked to Lewy body dementia.